A phase 2 study of actinium-225 ((225)Ac)-lintuzumab in older patients with previously untreated acute myeloid leukemia (AML) unfit for intensive chemotherapy Meeting Abstract
| Authors: | Finn, L. E.; Levy, M.; Orozco, J. J.; Park, J. H.; Atallah, E.; Craig, M.; Perl, A. E.; Scheinberg, D. A.; Cicic, D.; Bergonio, G. R.; Berger, M. S.; Jurcic, J. G. |
| Abstract Title: | A phase 2 study of actinium-225 ((225)Ac)-lintuzumab in older patients with previously untreated acute myeloid leukemia (AML) unfit for intensive chemotherapy |
| Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Dec 9-12 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-12-07 |
| Language: | English |
| ACCESSION: | WOS:000432419406271 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V130.Suppl_1.2638.2638 |
| Notes: | Meeting Abstract: 2638 -- Source: Wos |
